Twist Bioscience Corp — Form 8-K
Filed August 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Twist Bioscience registered up to 35,114 shares of common stock for resale by selling stockholder Invenra Inc. pursuant to a Stock Purchase Agreement dated February 11, 2026. The shares are being registered on Form S-3 filed June 18, 2026, with prospectus supplement dated August 19, 2026. This is a secondary offering—resale of shares previously issued, not new capital raised by Twist.
Why this rating
Routine secondary registration. 35,114 shares at ~$100/share = ~$3.5M, negligible vs. $2.3B market cap. No capital, no business change.
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.